STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

November 22, 2022

Period of Report

November 18, 2022

Accession Number

0001062993-22-022644